Evidence map›Paper›PMID 42621075›Full record

ArticleCureus2026

Primary Colonic Leiomyosarcoma Initially Diagnosed as Kaposi Sarcoma: A Case Report.

Ana Y Sandoval-Mussi, Dioselina Lanzagorta-Ortega, Ángela M Pérez-Paredes, Paris A Cisneros-Ramos, Saulo Mendoza-Ramírez, Enrique R Jean-Silver, Roberto R Hernández-Peña, Jorge A Ortiz de la Peña-Rodríguez

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana Y Sandoval-MussiGeneral Surgery, American British Cowdray Medical Center, Mexico City, MEX.
Dioselina Lanzagorta-OrtegaGeneral Surgery, American British Cowdray Medical Center, Mexico City, MEX.
Ángela M Pérez-ParedesMedicine and Surgery, Tecnológico de Monterrey, Mexico City, MEX.
Paris A Cisneros-RamosMedicine and Surgery, Tecnológico de Monterrey, Mexico City, MEX.
Saulo Mendoza-RamírezPathology, American British Cowdray Medical Center, Mexico City, MEX.
Enrique R Jean-SilverClinical Sciences, Tecnológico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, MEX.
Roberto R Hernández-PeñaOncology Surgery, American British Cowdray Medical Center, Mexico City, MEX.
Jorge A Ortiz de la Peña-RodríguezGeneral Surgery, American British Cowdray Medical Center, Mexico City, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary colonic leiomyosarcomas are relatively uncommon mesenchymal tumors, often posing diagnostic challenges due to their overlapping features with other gastrointestinal tumors. In this article, we report the case of a 61-year-old male who presented with abdominal pain and weight loss, whose initial endoscopic biopsy was interpreted as colonic Kaposi sarcoma, with tumor-cell positivity for cluster of differentiation 34 and human herpesvirus 8. Further surgical intervention, characterized by a right radical hemicolectomy and histopathological analysis, revealed a primary colonic leiomyosarcoma. This case highlights the diagnostic complexity associated with colonic leiomyosarcomas, the importance of comprehensive histopathological assessment, and the need for timely surgical management. The clinical course of the patient analyzed illustrates how misclassification can alter therapeutic strategies, underscoring the value of a timely and accurate diagnosis in guiding appropriate oncological management.

Indexed as

case reportcolon cancercolonic kaposi sarcomagastrointestinal stromal tumor (gist)immunohistochemistrysmooth muscle tumor

Identifiers

PMID42621075
PMCPMC13486379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.